Successful recanalization of total occlusion: No improvement of long-term survival

Original Title: Successful Recanalization of Native Coronary Chronic Total Occlusion Is Not Associated With Improved Long-Term Survival.
Reference: Pil Hyung Lee et al. J Am Coll Cardiol Intv. 2016. Online before print.

 

The aim of this study was to assess long term clinical outcomes after successful recanalization of chronic total occlusion (CTO) with DES implantation.

Between March 2003 and May 2014, 1173 native coronary CTO consecutive patients undergoing PCI were analyzed. DES were implanted in all successful procedures (1,004 patients, 85.6%).

At a median follow up of 4.6 years, all-cause mortality risk (HR: 1.04; IC 95% 0.53 to 2.04; p=0.92) and the combined risk of death and infarction (HR: 1.05 IC 95% 0.56 a 1.94; p=0.89) were comparable between successful and unsuccessful recanalization patients.

Neither were there differences between those patients with other compromised vessels, in addition to the one totally occluded (n=879), receiving complete revascularization, vs. those with incomplete revascularization for unsuccessful recanalization.

These finding were consistent between patients with multivessel disease and those with only the one occluded vessel.

Conclusion
Successful recanalization of CTO compared to unsuccessful recanalization was not associated with a reduction of hard events, such as death. However, successful recanalization was associated to a significate lower chance of CABG following CTO.

Editorial Comment
The different strategies to treat severely compromised, yet not occluded, vessels, the high rate of surgery following unsuccessful recanalization, and the high successful rate with very few serious complications, all contributed to the neutral outcome of this study.

The real prognostic impact of recanalizations should be decided between successful PCI vs. optimal medical treatment.

More articles by this author

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...